Keywords: zofran, approved, uk, ponv, glaxo, received, marketing

ZOFRAN APPROVED IN UK FOR PONV

Article | 11 May 1992

Print This

Glaxo has received marketing approval from the UK regulatory authorities for its 5-HT3 antagonist Zofran (ondansetron) as a treatment for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in